Science & Tech, Dec. 2 -- UK becomes the first country to license a vaccine against COVID-19, creating the opportunity for mass immunization with Pfizer and BioNTech vaccine.
Vaccination will begin in the areas most at risk, the vaccine was authorized for emergency use by the Medicines and Healthcare Products Regulatory Authority, before US-Europe decisions.
The MHRA was given the power to approve the vaccine under special regulations, the first doses of the vaccine are expected to arrive in the coming days.
Pfizer vaccine which has shown 95% efficacy in the final trials, was accepted for use.
After months of rigorous clinical trials and thorough analysis of the date by the expects at MHRA, concluded that the vaccine has met standards o...